AKRO icon

Akero Therapeutics
AKRO

Overview Fund Activity

146 hedge funds and large institutions have $1.73B invested in Akero Therapeutics in 2022 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 53 increasing their positions, 27 reducing their positions, and 16 closing their positions.

Holders
146
Holders Change
+33
Holders Change %
+29.2%
% of All Funds
2.53%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.12%
New
49
Increased
53
Reduced
27
Closed
16
Calls
$23.7M
Puts
$42.1M
Net Calls
-$18.4M
Net Calls Change
-$18.4M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$291M
2
APM
2
Avidity Partners Management
Texas
$106M
3
BBA
3
Baker Bros. Advisors
New York
$80.6M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$49.8M
5
RCM
5
RA Capital Management
Massachusetts
$32.7M

Top Sellers

1
VP
1
venBio Partners
California
$20.3M
2
AVLSA
2
Atlas Venture Life Science Advisors
Massachusetts
$33.9M
3
HA
3
HHLR Advisors
Cayman Islands
$23.2M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$0
5
Marshall Wace
5
Marshall Wace
United Kingdom
$25.6M
Name Market Value Shares Shares
Change 		Shares
Change %
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$291M 8,550,918 +5,482,606 +179%
ST
2
Skorpios Trust
Cyprus
$167M 4,907,829 – –
Alkeon Capital Management
3
Alkeon Capital Management
New York
$108M 3,162,259 +542,588 +21%
APM
4
Avidity Partners Management
Texas
$106M 3,122,000 +3,122,000 New
BBA
5
Baker Bros. Advisors
New York
$80.6M 2,368,378 +2,250,000 +1,901%
BlackRock
6
BlackRock
New York
$79.9M 2,345,477 +254,236 +12%
Goldman Sachs
7
Goldman Sachs
New York
$72.1M 2,118,797 +255,193 +14%
YCM
8
Yiheng Capital Management
California
$71.5M 2,099,146 +216,448 +11%
Vanguard Group
9
Vanguard Group
Pennsylvania
$59.3M 1,740,593 +429,579 +33%
RG
10
Redmile Group
California
$54.2M 1,591,085 +3,800 +0.2%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$49.8M 1,462,424 +1,007,122 +221%
RSCM
12
Rock Springs Capital Management
Maryland
$46.6M 1,369,973 +690,459 +102%
AVLSA
13
Atlas Venture Life Science Advisors
Massachusetts
$33.9M 994,251 -1,238,000 -55%
RCM
14
RA Capital Management
Massachusetts
$32.7M 958,980 +958,980 New
Adage Capital Partners
15
Adage Capital Partners
Massachusetts
$29.7M 872,500 +872,500 New
PBA
16
Paradigm Biocapital Advisors
New York
$28.4M 833,265 +833,265 New
BC
17
Boxer Capital
California
$28.3M 831,495 – –
Wellington Management Group
18
Wellington Management Group
Massachusetts
$27.1M 796,499 +94,019 +13%
DTC
19
Deep Track Capital
Connecticut
$26.9M 790,926 +790,926 New
Marshall Wace
20
Marshall Wace
United Kingdom
$25.6M 750,840 -254,842 -25%
CC
21
Commodore Capital
New York
$25.3M 743,472 +743,472 New
HA
22
HHLR Advisors
Cayman Islands
$23.2M 680,000 -679,052 -50%
VP
23
venBio Partners
California
$20.3M 596,483 -1,575,181 -73%
State Street
24
State Street
Massachusetts
$18.6M 547,622 +54,770 +11%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$17.8M 523,289 +55,304 +12%
1
2 3 4 5